Cellebrite Return On Equity vs. EBITDA

CLBT Stock  USD 19.72  0.46  2.28%   
Based on the measurements of profitability obtained from Cellebrite's financial statements, Cellebrite DI may not be well positioned to generate adequate gross income at the present time. It has a very high chance of underperforming in December. Profitability indicators assess Cellebrite's ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(2.37)
Current Value
(2.25)
Quarterly Volatility
0.9693118
 
Credit Downgrade
 
Yuan Drop
 
Covid
Price To Sales Ratio is likely to gain to 6.58 in 2024. Days Sales Outstanding is likely to gain to 112.46 in 2024. At this time, Cellebrite's Operating Income is comparatively stable compared to the past year. Net Income Applicable To Common Shares is likely to gain to about 145.9 M in 2024, whereas Interest Income is likely to drop slightly above 8.4 M in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.650.8363
Significantly Down
Pretty Stable
For Cellebrite profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cellebrite to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cellebrite DI utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cellebrite's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cellebrite DI over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellebrite. If investors know Cellebrite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cellebrite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Earnings Share
(1.58)
Revenue Per Share
1.928
Quarterly Revenue Growth
0.269
Return On Assets
0.0635
The market value of Cellebrite DI is measured differently than its book value, which is the value of Cellebrite that is recorded on the company's balance sheet. Investors also form their own opinion of Cellebrite's value that differs from its market value or its book value, called intrinsic value, which is Cellebrite's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cellebrite's market value can be influenced by many factors that don't directly affect Cellebrite's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cellebrite's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cellebrite is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cellebrite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cellebrite DI EBITDA vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Cellebrite's current stock value. Our valuation model uses many indicators to compare Cellebrite value to that of its competitors to determine the firm's financial worth.
Cellebrite DI is rated fifth in return on equity category among its peers. It also is rated fifth in ebitda category among its peers . At this time, Cellebrite's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Cellebrite by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Cellebrite EBITDA vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Cellebrite

Return On Equity

 = 

Net Income

Total Equity

 = 
-1.88
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Cellebrite

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(64.8 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Cellebrite EBITDA Comparison

Cellebrite is currently under evaluation in ebitda category among its peers.

Cellebrite Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Cellebrite, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cellebrite will eventually generate negative long term returns. The profitability progress is the general direction of Cellebrite's change in net profit over the period of time. It can combine multiple indicators of Cellebrite, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income1.1 M780.5 K
Net Interest Income-82.9 M-78.7 M
Interest Income8.9 M8.4 M
Operating Income33.2 M34.9 M
Net Loss-59.4 M-56.4 M
Income Before Tax-75.6 M-71.8 M
Total Other Income Expense Net-108.8 M-103.4 M
Net Income Applicable To Common Shares138.9 M145.9 M
Net Loss-81.1 M-77 M
Income Tax Expense5.5 MM
Change To Netincome-95.9 M-91.1 M
Net Loss(0.43)(0.41)
Income Quality(1.26)(1.20)
Net Income Per E B T 1.07  1.13 

Cellebrite Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Cellebrite. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cellebrite position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cellebrite's important profitability drivers and their relationship over time.

Use Cellebrite in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cellebrite position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellebrite will appreciate offsetting losses from the drop in the long position's value.

Cellebrite Pair Trading

Cellebrite DI Pair Trading Analysis

The ability to find closely correlated positions to Cellebrite could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cellebrite when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cellebrite - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cellebrite DI to buy it.
The correlation of Cellebrite is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cellebrite moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cellebrite DI moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cellebrite can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Cellebrite position

In addition to having Cellebrite in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Corporate Bonds Funds Thematic Idea Now

Corporate Bonds Funds
Corporate Bonds Funds Theme
Funds or Etfs investing in different types of corporate debt instruments. The Corporate Bonds Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate Bonds Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Cellebrite Stock Analysis

When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.